IOL Chemicals and Pharmaceuticals Financial Results
- Market cap
- ₹5,996 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹147.07 – ₹275.76
In the Q1 quarter, IOL Chemicals and Pharmaceuticals reported revenue of ₹480 crore, and net profit of ₹53.96 crore. The operating margin was 19%. Earnings per share were ₹9.08.
Summary
IOL Chemicals and Pharmaceuticals Limited is showing strong operational fundamentals with healthy volume activity and bullish technical indicators.
AI-generated summary of public data — not investment advice · 9 October 2026
IOL Chemicals and Pharmaceuticals quarterly results
Consolidated figures, newest quarter first.
| Item | Q1 |
|---|---|
| Revenue | 480 |
| Expenses | 390 |
| Operating profit | 89.94 |
| Operating margin % | 19% |
| Other income | 45 |
| Interest | 12 |
| Depreciation | 35 |
| Profit before tax | 71.95 |
| Tax % | 25% |
| Net profit | 53.96 |
| EPS (₹) | 9.08 |
IOL Chemicals and Pharmaceuticals annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | FY25 |
|---|---|
| Revenue | 2,099 |
| Expenses | 1,679 |
| Operating profit | 420 |
| Operating margin % | 20% |
| Other income | 180 |
| Interest | 50 |
| Depreciation | 140 |
| Profit before tax | 330 |
| Tax % | 25% |
| Net profit | 246 |
| EPS (₹) | 36.31 |
| Dividend payout % | 22% |
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
IOL Chemicals and Pharmaceuticals financial results — frequently asked questions
What were IOL Chemicals and Pharmaceuticals' latest quarterly results?
For the Q1 quarter (consolidated), IOL Chemicals and Pharmaceuticals reported revenue of ₹480 crore, operating profit of ₹89.94 crore and net profit of ₹53.96 crore, with EPS of ₹9.08.
What is IOL Chemicals and Pharmaceuticals' annual revenue and net profit?
For the financial year ended FY25, IOL Chemicals and Pharmaceuticals' revenue was ₹2,099 crore and net profit ₹246 crore.
What is the EPS of IOL Chemicals and Pharmaceuticals?
Quarterly EPS for Q1 was ₹9.08. Annual EPS for FY25 was ₹36.31.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade IOL Chemicals and Pharmaceuticals With ATS
Track IOLCP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.